Prostate and testicular cancers represent two distinct malignancies of the male reproductive system with significant implications for men's health, longevity, and quality of life. The prostate gland is a walnut-sized organ located directly beneath the bladder, surrounding the urethra, primarily responsible for producing fluid that nourishes and transports sperm. Conversely, the testicles are paired oval organs housed within the scrotum, tasked with producing testosterone and spermatozoa. While prostate cancer typically affects older men and tends to grow slowly, testicular cancer frequently targets younger adult males between the ages of fifteen and thirty-five and often exhibits a rapid growth rate paired with high cure rates.
Understanding the epidemiology of male reproductive cancers in West Africa highlights crucial public health challenges. Prostate cancer incidence and mortality rates are notably high among men of African descent, driven by a combination of genetic predispositions, hormonal factors, and delayed presentation at health facilities. Advanced age, a positive family history of the disease, and diets high in animal fat also elevate prostate cancer risk. Testicular cancer remains comparatively rare in Nigeria, though its exact etiology involves cryptorchidism (undescended testicles), genetic factors, and abnormal testicular development.
Early detection remains the cornerstone of reducing mortality from both prostate and testicular malignancies. For prostate cancer, screening relies on the Digital Rectal Examination (DRE) and serum Prostate-Specific Antigen (PSA) testing, allowing clinicians to detect abnormalities before symptoms arise. In contrast, testicular cancer screening depends heavily on self-awareness and education. Midwives and nurses must actively promote Testicular Self-Examination (TSE) among young men, encouraging them to check their scrotal contents monthly after a warm bath or shower when the scrotal skin is relaxed.
Malignancies in the reproductive tract often present with subtle symptoms in their early stages, leading many patients to seek care only when the disease has advanced.
Clinicians must maintain a high index of suspicion when middle-aged or elderly men present with persistent lower urinary tract symptoms that fail to respond to standard antibiotic therapy for prostatitis.
Confirming a diagnosis requires moving beyond clinical screening to definitive diagnostic investigations. For suspected prostate malignancy, a transrectal ultrasound-guided (TRUS) core needle biopsy provides tissue histopathology to grade the tumor using the Gleason scoring system. For testicular masses, an initial scrotal ultrasound is performed, followed by radical inguinal orchiectomy—removing the affected testicle through the groin—since transscrotal biopsy risks tumor spillage. Serum tumor markers such as alpha-fetoprotein (AFP), beta-human chorionic gonadotropin ($eta$-hCG), and lactate dehydrogenase (LDH) are essential for staging and monitoring testicular cancer.
Treatment modalities vary based on the specific cancer type, stage, and the patient's overall health status.
| Cancer Type | Common Treatment Options |
|---|---|
| Localized Prostate Cancer | Active surveillance, radical prostatectomy, external beam radiotherapy |
| Advanced Prostate Cancer | Androgen deprivation therapy (ADT), chemotherapy, palliative care |
| Testicular Cancer | Radical inguinal orchiectomy, adjuvant chemotherapy, retroperitoneal lymph node dissection |
Testicular cancer is exceptionally responsive to chemotherapy even in advanced stages, offering high cure rates, whereas prostate cancer management often balances tumor control against preserving urinary and sexual function.
Caring for men diagnosed with reproductive cancers demands a compassionate, culturally sensitive approach that addresses both physical healing and psychological well-being. Midwives and nurses play a vital role in managing post-operative surgical sites, monitoring urinary catheter patency, and administering prescribed analgesics. Furthermore, treatments often threaten a man's body image, sexual potency, and fertility, triggering anxiety, depression, and stigma. Healthcare providers must facilitate open communication, offer supportive counseling, and connect patients and their families with reliable survivorship support networks.